GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Bio-Sincerity Pharma-Tech Co Ltd (SZSE:301096) » Definitions » Additional Paid-In Capital

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Bio-Sincerity Pharma-Tech Co Additional Paid-In Capital?


Hangzhou Bio-Sincerity Pharma-Tech Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥2,057 Mil) but then stayed the same from Dec. 2023 (¥2,057 Mil) to Mar. 2024 (¥0 Mil).

Hangzhou Bio-Sincerity Pharma-Tech Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥2,006 Mil) to Dec. 2022 (¥2,006 Mil) but then increased from Dec. 2022 (¥2,006 Mil) to Dec. 2023 (¥2,057 Mil).


Hangzhou Bio-Sincerity Pharma-Tech Co Additional Paid-In Capital Historical Data

The historical data trend for Hangzhou Bio-Sincerity Pharma-Tech Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Bio-Sincerity Pharma-Tech Co Additional Paid-In Capital Chart

Hangzhou Bio-Sincerity Pharma-Tech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial 169.48 169.30 2,005.69 2,005.69 2,057.04

Hangzhou Bio-Sincerity Pharma-Tech Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2,020.65 - 2,057.04 -

Hangzhou Bio-Sincerity Pharma-Tech Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Hangzhou Bio-Sincerity Pharma-Tech Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hangzhou Bio-Sincerity Pharma-Tech Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Business Description

Traded in Other Exchanges
N/A
Address
611 Dongguan Road, 2nd Floor, Building 8, Jinsheng Technology Park, Binjiang District, Hangzhou, CHN
Hangzhou Bio-Sincerity Pharma-Tech Co Ltd is a pharmaceutical technology research and development company. The company's business covers drug discovery, pharmaceutical research, clinical research, and registration application.

Hangzhou Bio-Sincerity Pharma-Tech Co (SZSE:301096) Headlines

No Headlines